Send us Feedback

Neurocrine Biosciences (NBIX)
QUOTE AND NEWS
Neurocrine Biosciences (NBIX) Presents Phase I and Phase II Elagolix Data
StreetInsider.com  Jun 16 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Neurocrine+Biosciences+%28NBIX%29+Presents+Phase+I+and+Phase+II+Elagolix+Data/4735543.html for the full story.
Neurocrine Biosciences Reports First Quarter 2009 Results
PR News Wire  May 5 
SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended March 31, 2009. For the first quarter of 2009, the Company reported a net loss of $19.7 million, or
These 5 Underdogs Are No Dogs
Motley Fool  Apr 29 
Like smart hedge fund operators, these investors bet against a stock -- and won big.
Last Chance to Get in on This No-Brainer Biotech Trade
Contrarian Profits  Apr 11 
Back in December, I told you the bleak story of Neurocrine Biosciences (NBIX). A week earlier, the company had received a crushing blow from the FDA, dished out in a notorious "approvable letter." Approvable letters are the FDA's way of turning...
Neurocrine’s FDA Rejection Bodes Well For Sepracor
Pharma's Cutting Edge  May 16 
Folks...I'll say this until I'm blue in the face, because it's really important. Don't let ignorance of FDA's approval decision-making processes and recent history be an excuse for an NME approval delay. Investor's--who've crushed Neurocrine's...
Suggest other news sources for this topic
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
See All
BULLS: REASONS TO BUY
Bulls: Reasons To Buy
Feeling Bullish? Be the first to explain why this would make a good investment
See All (0)
See All
BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish? Be the first to explain why this would make a poor investment
See All (0)
more ▼EditWIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Neurocrine Biosciences (NBIX):
 
NBIX AT A GLANCE
 
 
 
 
 
 
 
 
Please install Flash Player to view this chart.



[edit] References

Retrieved from "http://www.wikinvest.com/stock/Neurocrine_Biosciences_(NBIX)"
 
Worried about pump and dump?
We review changes
for stock spam
» read more
Want to make Wikinvest better?
We need your help,
contribute today
» learn how
Do you write software?
We are recruiting
the best engineers
» view jobs
Like Wikinvest?
Spread the word —
Tell your friends!
» spread the word
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki